Status:
COMPLETED
Efficacy of SASI Bypass in Super Obese Patients
Lead Sponsor:
Mansoura University
Conditions:
Morbid Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Although previous studies investigated weight loss and improvement in comorbidities after SASI bypass, patients included in these studies had a BMI less than 50 Kg/m2. Therefore, the aim of the presen...
Eligibility Criteria
Inclusion
- Patients included to the present study were adult patients of both genders aging between 18 and 65 years with primary morbid obesity with BMI ≥50 kg/m2 with or without obesity-associated comorbidities such as hypertension, diabetes mellitus (DM), dyslipidemias, and gastroesophageal reflux disease (GERD).
Exclusion
- Pregnant women.
- Patients unfit for general anasthesia (ASA 4, 5)
- Endocrine or psychiatric disorders.
- History of previous upper abdmominal laparotomy.
- Alcoholic addiction
- Liver cirrhosis
- Coagulopathy
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04037670
Start Date
July 1 2017
End Date
July 20 2019
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura university hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35516